Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Melphalan Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 221,400Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CASI Pharmaceuticals To Present At The Jefferies 2020 Healthcare Conference
    CASI Pharmaceuticals To Present At The Jefferies 2020 Healthcare Conference

    02 Jun 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/casi-pharmaceuticals-to-present-at-the-jefferies-2020-healthcare-conference-301068743.html

    PRNEWSWIRE
    02 Jun 2020
    Share Share
    BPI Labs Llc Generic Melphalan Hydrochloride Receives Approval In US
    BPI Labs Llc Generic Melphalan Hydrochloride Receives Approval In US

    13 May 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209197

    FDA
    13 May 2020
    Share Share
    Actavis ’s Generic Melphalan Hydrochloride Receives Approval In US
    Actavis ’s Generic Melphalan Hydrochloride Receives Approval In US

    11 Mar 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209323

    FDA
    11 Mar 2020
    Share Share
    Ingenus Pharms`s Generic Melphalan Hydrochloride Receives Approval in US
    Ingenus Pharms`s Generic Melphalan Hydrochloride Receives Approval in US

    20 Feb 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210947

    FDA
    20 Feb 2020
    Share Share
    Delcath Completes Enrollment in its United States Registration Pivotal Trial
    Delcath Completes Enrollment in its United States Registration Pivotal Trial

    13 Jan 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/01/13/1969602/0/en/Delcath-Completes-Enrollment-in-its-United-States-Registration-Pivotal-Trial-FOCUS-Investigating-Melphalan-HDS-in-the-Treatment-of-Patients-with-Unresectable-Hepatic-Dominant-Ocula.html

    GLOBENEWSWIRE
    13 Jan 2020
    Share Share
    Gland Pharma`s Generic Melphalan Hydrochloride Receives Approval in US
    Gland Pharma`s Generic Melphalan Hydrochloride Receives Approval in US

    31 May 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209826

    FDA
    31 May 2019
    Share Share